A Case of Hemolytic Disease of Newborn due to Anti-Dia: Consideration of the Inclusion of Dia Antigen in Antibody Screening Test-Reference-Cited by-同舟云学术

A Case of Hemolytic Disease of Newborn due to Anti-Dia: Consideration of the Inclusion of Dia Antigen in Antibody Screening Test

Published:2019-12-31 Issue:3 Volume:30 Page:241-245
ISSN:1226-9336
Container-title:The Korean Journal of Blood Transfusion
language:en
Short-container-title:KJBT

Author:

Kim Han-Sol¹,Jo Chae-Ku¹,Kim Sin-Young²^ORCID,Kim Kyeong-Hee³^ORCID,Kim Myo-Jing⁴^ORCID

Affiliation:

1. Department of Pediatrics, Dong-A University Hospital, Busan, Korea

2. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea

3. Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea

4. Department of Pediatric, Dong-A University College of Medicine, Busan, Korea

Publisher

The Korean Society of Blood Transfusion

Link

http://pdf.medrang.co.kr/KJBT/2019/030/KJBT030-03-06.pdf

Reference11 articles.

1. Further Analysis of Korean Blood Types

2. Sung NH, Jeon TY, Lee EY, Chung JS, Cho GJ, Kim HH. Prevalence and specificity of unexpected antibody using antibody screening test including dia and mia cells. Korean J Lab Med 2005;25:340-6.

3. Chung MA, Park EH, Lee CH, Oh CH, Namgung R, Kim HO et al. A case of hemolytic disease in the newborn due to anti-dia antibody. J Korean Soc Neonatol 2001;8:141-4.

4. A Case of Severe Hemolytic Disease of the Newborn Due to Anti-DiaAntibody

5. Kim HC, Kang MJ, Chae JH, Shim WS, Nahm CH, Han KS. A case of hemolytic disease of the newborn due to anti-dib antibody. Korean J Blood Transfus 1994;5:151-7.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing the Number of Panel Cells for Unexpected Antibody Screening: Is It Economically Worth It?;The Korean Journal of Blood Transfusion;2023-04-30

2. Comparison between Screening Cells Including Di^a and Mi^a Antigen for Unexpected Antibody Screening;The Korean Journal of Blood Transfusion;2022-04-30